357 related articles for article (PubMed ID: 26864092)
21. Pravastatin: an evidence-based statin?
del Sol AI; Nanayakkara PW
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):821-5. PubMed ID: 18611121
[TBL] [Abstract][Full Text] [Related]
22. The anatomy of a clinical trial. The West of Scotland Coronary Prevention Study.
Shepherd J; Gaw A;
Med Princ Pract; 2002; 11 Suppl 2():17-30. PubMed ID: 12444307
[TBL] [Abstract][Full Text] [Related]
23. Statins for children with familial hypercholesterolemia.
Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006401. PubMed ID: 28685504
[TBL] [Abstract][Full Text] [Related]
24. Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction – ALPS-AMI study.
Izawa A; Kashima Y; Miura T; Ebisawa S; Kitabayashi H; Yamamoto H; Sakurai S; Kagoshima M; Tomita T; Miyashita Y; Koyama J; Ikeda U;
Circ J; 2015; 79(1):161-8. PubMed ID: 25392071
[TBL] [Abstract][Full Text] [Related]
25. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
26. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Cannon CP; Braunwald E; McCabe CH; Rader DJ; Rouleau JL; Belder R; Joyal SV; Hill KA; Pfeffer MA; Skene AM;
N Engl J Med; 2004 Apr; 350(15):1495-504. PubMed ID: 15007110
[TBL] [Abstract][Full Text] [Related]
27. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
28. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
[TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults.
Carlsson CM; Papcke-Benson K; Carnes M; McBride PE; Stein JH
Drugs Aging; 2002; 19(10):793-805. PubMed ID: 12390056
[TBL] [Abstract][Full Text] [Related]
30. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
31. The effects of pravastatin on hospital admission in hypercholesterolemic middle-aged men: West of Scotland Coronary Prevention Study.
J Am Coll Cardiol; 1999 Mar; 33(4):909-15. PubMed ID: 10091815
[TBL] [Abstract][Full Text] [Related]
32. Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials.
Burton JK; Papworth R; Haig C; McCowan C; Ford I; Stott DJ; Quinn TJ
Drugs Aging; 2018 Jul; 35(7):657-663. PubMed ID: 29916140
[TBL] [Abstract][Full Text] [Related]
33. Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke).
Hosomi N; Kitagawa K; Nagai Y; Nakagawa Y; Aoki S; Nezu T; Kagimura T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Matsumoto M;
Stroke; 2018 Apr; 49(4):865-871. PubMed ID: 29511130
[TBL] [Abstract][Full Text] [Related]
34. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
35. Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.
Sasaki S; Nakagawa M; Nakata T; Azuma A; Sawada S; Takeda K; Asayama J;
Circ J; 2002 Jan; 66(1):47-52. PubMed ID: 11999665
[TBL] [Abstract][Full Text] [Related]
36. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
Bruckert E; Ferrières J
Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
[TBL] [Abstract][Full Text] [Related]
37. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.
Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL
JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313
[TBL] [Abstract][Full Text] [Related]
38. Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
Simes RJ; Marschner IC; Hunt D; Colquhoun D; Sullivan D; Stewart RA; Hague W; Keech A; Thompson P; White H; Shaw J; Tonkin A;
Circulation; 2002 Mar; 105(10):1162-9. PubMed ID: 11889008
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
Wiegman A; Hutten BA; de Groot E; Rodenburg J; Bakker HD; Büller HR; Sijbrands EJ; Kastelein JJ
JAMA; 2004 Jul; 292(3):331-7. PubMed ID: 15265847
[TBL] [Abstract][Full Text] [Related]
40. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Giugliano RP; Cannon CP; Blazing MA; Nicolau JC; Corbalán R; Špinar J; Park JG; White JA; Bohula EA; Braunwald E;
Circulation; 2018 Apr; 137(15):1571-1582. PubMed ID: 29263150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
